ArticleFrontiers in oncology2026

Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and thrombocytopenia: a case report.

Jinjin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.